Barza M
Department of Medicine, Tufts University School of Medicine, Boston, MA, USA.
New Horiz. 1996 Aug;4(3):333-7.
Antibiotic resistance is a growing problem, affecting microorganisms found both in hospitals and in the community. In most patients, resistant organisms arise by transmission of already resistant microorganisms from another person, rather than arising by mutation in the index patient. Antibiotic resistance genes are often borne on plasmids or transposons on which they may be spread rapidly to other organisms in the same species or in other species. Plasmids and transposons readily pick up genes for resistance to other antibiotics or nonantibiotic agents ("linked resistance"). Control of the spread of antibiotic resistance may require limitation of the usage of other agents with linked resistance as well as of the antibiotics of primary interest. A model is described for the analysis of the transmission of antibiotic-resistant enteric bacteria in the ICU. The model deals with the baseline level of antibiotic resistance in the "source" patient, the effect of antibiotics in augmenting the concentration of resistant organisms in that patient, the role of patient-to-patient contact, and factors which may influence the "colonizability" of the recipient patient. Possible measures to reduce the spread of antibiotic resistance are discussed. It is hoped that the model may serve to focus discussion on some key ingredients of the transmission cycle.
抗生素耐药性是一个日益严重的问题,影响着医院和社区中的微生物。在大多数患者中,耐药微生物是通过已具有耐药性的微生物从另一个人传播而来,而非由索引患者自身发生突变产生。抗生素耐药基因通常携带在质粒或转座子上,它们可以迅速传播到同一物种或其他物种的其他微生物中。质粒和转座子很容易获取对其他抗生素或非抗生素药物的耐药基因(“连锁耐药性”)。控制抗生素耐药性的传播可能需要限制使用具有连锁耐药性的其他药物以及主要关注的抗生素。本文描述了一个用于分析重症监护病房中耐抗生素肠道细菌传播的模型。该模型涉及“源”患者中抗生素耐药性的基线水平、抗生素对该患者体内耐药微生物浓度增加的影响、患者之间接触的作用以及可能影响接受者患者“可定植性”的因素。文中讨论了减少抗生素耐药性传播的可能措施。希望该模型有助于聚焦对传播循环中一些关键因素的讨论。